Literature DB >> 31759825

Emerging Research in Transfusion Medicine: What to Expect in 2020.

Sunny Dzik1, Mike Murphy2.   

Abstract

Mesh：

Year:  2019        PMID： 31759825     DOI： 10.1016/j.tmrv.2019.11.006

Source DB:  PubMed          Journal:  Transfus Med Rev        ISSN： 0887-7963


× No keyword cloud information.
  10 in total

1.  Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study.

Authors:  Johanna C Wiersum-Osselton; Barbee Whitaker; Sharran Grey; Kevin Land; Gabriela Perez; Srijana Rajbhandary; Chester Andrzejewski; Paula Bolton-Maggs; Harriet Lucero; Philippe Renaudier; Pierre Robillard; Matilde Santos; Martin Schipperus
Journal:  Lancet Haematol       Date:  2019-05-09       Impact factor: 18.959

2.  Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children.

Authors:  W J Rodriguez; W C Gruber; J R Groothuis; E A Simoes; A J Rosas; M Lepow; A Kramer; V Hemming
Journal:  Pediatrics       Date:  1997-12       Impact factor: 7.124

3.  Transfusion-associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010.

Authors:  Andrea Piccin; Marina Cronin; Róisín Brady; Jackie Sweeney; Luigi Marcheselli; Emer Lawlor
Journal:  Transfusion       Date:  2014-12-18       Impact factor: 3.157

4.  Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

Authors:  Ivan F N Hung; Kelvin K W To; Cheuk-Kwong Lee; Kar-Lung Lee; Wing-Wa Yan; Kenny Chan; Wai-Ming Chan; Chun-Wai Ngai; Kin-Ip Law; Fu-Loi Chow; Raymond Liu; Kang-Yiu Lai; Candy C Y Lau; Shao-Haei Liu; Kwok-Hung Chan; Che-Kit Lin; Kwok-Yung Yuen
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

Review 5.  Erythropoietin in cancer: presumption of innocence?

Authors:  C Anthony Blau
Journal:  Stem Cells       Date:  2007-04-26       Impact factor: 6.277

6.  Epitopes required for antibody-dependent enhancement of Ebola virus infection.

Authors:  Ayato Takada; Hideki Ebihara; Heinz Feldmann; Thomas W Geisbert; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

7.  Antibody-dependent enhancement of severe dengue disease in humans.

Authors:  Leah C Katzelnick; Lionel Gresh; M Elizabeth Halloran; Juan Carlos Mercado; Guillermina Kuan; Aubree Gordon; Angel Balmaseda; Eva Harris
Journal:  Science       Date:  2017-11-02       Impact factor: 47.728

8.  Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies.

Authors:  Patrice Guillon; Monique Clément; Véronique Sébille; Jean-Gérard Rivain; Chih-Fong Chou; Nathalie Ruvoën-Clouet; Jacques Le Pendu
Journal:  Glycobiology       Date:  2008-09-25       Impact factor: 4.313

Review 9.  Fc receptors in antibody-dependent enhancement of viral infections.

Authors:  Adam Taylor; Suan-Sin Foo; Roberto Bruzzone; Luan Vu Dinh; Nicholas J C King; Suresh Mahalingam
Journal:  Immunol Rev       Date:  2015-11       Impact factor: 12.988

10.  Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.

Authors:  Sheng-Fan Wang; Sung-Pin Tseng; Chia-Hung Yen; Jyh-Yuan Yang; Ching-Han Tsao; Chun-Wei Shen; Kuan-Hsuan Chen; Fu-Tong Liu; Wu-Tse Liu; Yi-Ming Arthur Chen; Jason C Huang
Journal:  Biochem Biophys Res Commun       Date:  2014-07-26       Impact factor: 3.575
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.